RFI - Enhanced Maritime Biological Detection (EMBD)

The Enhanced Maritime Biological Detection (EMBD) program is charged with finalizing development, and complete testing, integration and production of an automated biological warfare agent point detection system.

The EMBD program has issued a Special Notice to receive feedback from industry regarding a Draft Performance Work Statement (PWS) for the planned technology upgrade to the existing Joint Biological Point Detection System (JBPDS).

The U.S. Navy will integrate an EMBD retrofit kit into a fielded JBPDS. The contractor will build upon the upgrade efforts completed under the JBPDS production contract, utilizing five Line Replaceable Units (LRUs) that perform the following core biological defense functions:

Detection (Rapid Agent Aerosol Detector (RAAD))
Collection (Wetted Wall Cyclone (WWC) Collector)
Identification (Lateral Flow Immunoassay Identifier)
Sample Handling (Fluid Transfer System (FTS))
Local User Interface (Computing and Control Subsystem (CCS))

The LRUs are integrated into the Biosuite Enclosure (BSE) and receive conditioned power from the Power Pack. EMBD can be controlled locally by the CCS and remotely by the External Controller Subsystem (ECS).

The objective of the EMBD acquisition is to develop and produce EMBD systems for Engineering and Manufacturing Development (EMD), First Article Testing, Logistics and Government Testing. As part of EMD, the Government will provide 10 legacy JBPDS units to the Contractor and the Contractor will be responsible to convert each into an EMBD system.

Requirements include EMD engineering, development and manufacture of hardware, support of Government program, testing and logistics efforts and delivery of technical data. The EMBD acquisition also includes options for Low Rate Initial Production (LRIP) and Full Rate Production (FRP) of EMBD retrofit kits.

Further details are available via Solicitation Number: EMBD_PWS. The response deadline is Sep 11, 2017 4:00 pm Eastern.